simponi solution
janssen inc - golimumab - solution - 50mg - golimumab 50mg - disease-modifying antirheumatic agents
remsima sc trousse
celltrion healthcare co ltd - infliximab - trousse - 120mg - infliximab 120mg - disease-modifying antirheumatic agents
remsima sc solution
celltrion healthcare co ltd - infliximab - solution - 120mg - infliximab 120mg - disease-modifying antirheumatic agents
brenzys solution
samsung bioepis co., ltd - Étanercept - solution - 50mg - Étanercept 50mg - disease-modifying antirheumatic agents
brenzys solution
samsung bioepis co., ltd - Étanercept - solution - 50mg - Étanercept 50mg - disease-modifying antirheumatic agents
erelzi solution
sandoz canada incorporated - Étanercept - solution - 50mg - Étanercept 50mg - disease-modifying antirheumatic agents
erelzi solution
sandoz canada incorporated - Étanercept - solution - 50mg - Étanercept 50mg - disease-modifying antirheumatic agents
erelzi solution
sandoz canada incorporated - Étanercept - solution - 25mg - Étanercept 25mg - disease-modifying antirheumatic agents
rymti solution
lupin pharma canada limited - Étanercept - solution - 25mg - Étanercept 25mg
rymti solution
lupin pharma canada limited - Étanercept - solution - 50mg - Étanercept 50mg